Market Research Logo

Benign Prostatic Hyperplasia - Pipeline Review, H2 2018

Benign Prostatic Hyperplasia - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperplasia - Pipeline Review, H2 2018, provides an overview o


Introduction 5
Benign Prostatic Hyperplasia - Overview 6
Benign Prostatic Hyperplasia - Therapeutics Development 7
Benign Prostatic Hyperplasia - Therapeutics Assessment 15
Benign Prostatic Hyperplasia - Companies Involved in Therapeutics Development 23
Benign Prostatic Hyperplasia - Drug Profiles 33
Benign Prostatic Hyperplasia - Dormant Projects 95
Benign Prostatic Hyperplasia - Discontinued Products 98
Benign Prostatic Hyperplasia - Product Development Milestones 99
Appendix 109
List of Tables
Number of Products under Development for Benign Prostatic Hyperplasia, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Aphios Corp, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Aquestive Therapeutics Inc, H2 2018
Benign Prostatic Hyperplasia - Pipeline by ASKA Pharmaceutical Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by BCWorld Pharm Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Biolab Farmaceutica Ltda, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Curadis GmbH, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Dongkook Pharmaceutical Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by GemVax & KAEL Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Health Ever Bio-Tech Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Kissei Pharmaceutical Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Meiji Seika Pharma Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Mezzion Pharma Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Nymox Pharmaceutical Corp, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Ono Pharmaceutical Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by OPKO Health Inc, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Sophiris Bio Inc, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by XuanZhu Pharma Co Ltd, H2 2018
Benign Prostatic Hyperplasia - Pipeline by Yuyu Pharma Inc, H2 2018
Benign Prostatic Hyperplasia - Dormant Projects, H2 2018
Benign Prostatic Hyperplasia - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Benign Prostatic Hyperplasia, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report